News Abbott Laboratories Swiss Exchange

Stocks

ABT

US0028241000

Medical Equipment, Supplies & Distribution

Market Closed - Swiss Exchange Other stock markets 18:35:33 03/08/2026 +03			5-day change	1st Jan Change
86.50 ^CHF	+1.76%		+2.37%	-12.63%

03:34pm	Is everything under control?
08-01	Amgen discloses data breach involving patient health information	RE

All News

Mentions Relevance

07-28	Tranche Update on Abbott Laboratories's Equity Buyback Plan announced on October 16, 2024.	CI
07-28	UBS Adjusts Price Target on Abbott Laboratories to $125 From $135, Maintains Buy Rating	MT
07-28	Abbott Laboratories : initiates clinical study to show outcomes for real-world use of TriClip™ in repairing leaky tricuspid heart valve	PU
07-28	Rothschild & Co Redburn Adjusts PT on Abbott Laboratories to $119 From $126, Maintains Neutral Rating	MT
07-27	Freenome, Abbott Laboratories' Colorectal Cancer Screening Test Approved by FDA; Freenome Earns $100 Million Milestone Payment	MT
07-25	Abbott defeats shareholder lawsuit over 2022 infant formula recall	RE
07-24	Abbott wins dismissal of shareholder lawsuit over 2022 infant formula recall	RE
07-23	Daiwa Securities Adjusts Price Target on Abbott Laboratories to $103 From $92, Maintains Neutral Rating	MT
07-22	Leerink Partners Adjusts Price Target on Abbott Laboratories to $109 From $106, Maintains Market Perform Rating	MT
07-18	Abbott investigates two separate cyber incidents, says no operations affected	RE
07-17	Abbott Laboratories Seen on Track for H2 Growth Acceleration, RBC Says	MT
07-17	JPMorgan Adjusts Price Target on Abbott Laboratories to $120 From $110, Maintains Overweight Rating	MT
07-17	Piper Sandler Adjusts Price Target on Abbott Laboratories to $118 From $115, Maintains Overweight Rating	MT
07-17	BTIG Adjusts Price Target on Abbott Laboratories to $134 From $131, Maintains Buy Rating	MT
07-17	Citigroup Adjusts Price Target on Abbott Laboratories to $112 From $108, Maintains Buy Rating	MT
07-17	Bernstein Adjusts Price Target on Abbott Laboratories to $117 From $110, Maintains Outperform Rating	MT
07-17	Evercore ISI Adjusts Price Target on Abbott Laboratories to $120 From $112, Maintains Outperform Rating	MT
07-17	Army integrating new handheld device to quickly assess brain injuries	AQ
07-16	Wells Fargo Raises Abbott Laboratories Price Target to $112 From $109	MT
07-16	Abbott Boosts 2026 Profit Guidance as Sales Across Business Rise	MT
07-16	Abbott Laboratories Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
07-16	Abbott Laboratories, Q2 2026 Earnings Call, Jul 16, 2026
07-16	Abbott Laboratories Raises Full-Year Earnings Guidance as Second-Quarter Results Top Views	MT
07-16	Abbott Laboratories : ABT 2026 Q2 Exhibit 99.1 FINAL	PU
07-16	Abbott Laboratories 2Q Sales Rise on Diagnostics Growth	DJ